Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01382069 · ClinicalTrials.gov registry record · Phase 1
Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men
A Phase 1 study of Male Contraception and Healthy Men, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT01382069 is a Phase 1 study of Male Contraception and Healthy Men that has completed, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 100 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT01382069, a Phase 1 study of Male Contraception and Healthy Men, has completed, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The long term objective is to develop a new male hormone Dimethandrolone Undecanoate (DMAU) as a male hormonal contraceptive. The study has two parts. The first is a dose escalating study in healthy to assess the safety and tolerability of single dose oral administration of DMAUin healthy men.(Completed) The second is to study the safety and tolerability of DMAU after 28 days of repeated daily dosing of DMAU in healthy men. (Currently Recruiting) In both parts the investigators will also study the pharmacokinetics of Dimethandrolone (DMA) in the serum after oral administration of DMAU.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Dimethandrolone Undecanoate
Study Locations (2)
California
- Los Angeles Biomedical Research Institute - Torrance
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2012-03 |
| Est. Completion | 2017-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01382069
The ClinicalTrials.gov registry entry for NCT01382069 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Male Contraception appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01382069 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Washington.
Frequently Asked Questions
What is clinical trial NCT01382069 about?
NCT01382069 is a clinical study titled "Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men". The long term objective is to develop a new male hormone Dimethandrolone Undecanoate (DMAU) as a male hormonal contraceptive. The study has two parts. The first is a dose escalating study in healthy to assess the safety and tolerability of single dose oral administration of DMAUin healthy men.(Comp...
What is the current status of trial NCT01382069?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2012-03. Estimated completion is 2017-05.
What conditions does trial NCT01382069 study?
This clinical trial studies the following conditions: Male Contraception, Healthy Men.
What interventions are being tested in trial NCT01382069?
The interventions under investigation include: Placebo (DRUG), Dimethandrolone Undecanoate (DRUG).
Who is sponsoring clinical trial NCT01382069?
This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01382069 being conducted?
This trial has 2 study locations across California, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Male Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.